Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway.
Cheng, Wen-Fang
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Nov 2005 - 960-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1525-0016
10.1016/j.ymthe.2005.04.020 doi
Animals
CD8-Positive T-Lymphocytes--immunology
Cancer Vaccines
Cell Line, Tumor
Down-Regulation
Fas Ligand Protein
Female
Genetic Therapy
Histocompatibility Antigens Class I
Interferon-gamma--metabolism
Membrane Glycoproteins--biosynthesis
Mice
Mice, Inbred C57BL
Neoplasms, Experimental--metabolism
T-Lymphocytes, Cytotoxic--metabolism
Tumor Necrosis Factors--biosynthesis
Vaccines, DNA
fas Receptor--metabolism
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Nov 2005 - 960-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1525-0016
10.1016/j.ymthe.2005.04.020 doi
Animals
CD8-Positive T-Lymphocytes--immunology
Cancer Vaccines
Cell Line, Tumor
Down-Regulation
Fas Ligand Protein
Female
Genetic Therapy
Histocompatibility Antigens Class I
Interferon-gamma--metabolism
Membrane Glycoproteins--biosynthesis
Mice
Mice, Inbred C57BL
Neoplasms, Experimental--metabolism
T-Lymphocytes, Cytotoxic--metabolism
Tumor Necrosis Factors--biosynthesis
Vaccines, DNA
fas Receptor--metabolism